CME Group posts record Q3 revenue and adjusted EPS beat, but shares dip on guidance concerns

CME Group reported third‑quarter 2026 revenue of $1.7 billion and adjusted diluted earnings per share of $3.02, both beating analysts’ estimates. The quarter also set a record average daily volume of 29.4 million contracts and returned nearly $1 billion to shareholders via dividends and share repurchases. Despite the beat, the stock fell about 2% in pre‑market trading as investors expressed concern over the company’s forward‑looking guidance.

The earnings beat and record volume highlight CME’s strong market position, but the share‑price decline reflects investor worries that the guidance may not sustain the growth trajectory (as noted). The dividend yield of 4.04% and high payout ratio of 95% also raise sustainability questions for income‑focused investors ().

  • 1Revenue for Q3 2026 was $1.7 billion ().
  • 2Adjusted diluted EPS for Q3 2026 was $3.02 ().
  • 3Net income for Q3 2026 was $1.0 billion ().
  • 4Average daily volume reached a record 29.4 million contracts ().
  • 5The company returned nearly $1 billion to shareholders, including $465 million in dividends and $524 million in share repurchases ().
  • 6Dividend yield is 4.04% and payout ratio is 95% ().

Sources